Research projects
Cima Universidad de Navarra
-
Immunology and ImmunotherapyActive
XPRIME. Exploring and exploiting cross-priming in cancer immunotherapy
Cima Principal Investigator: Álvaro Teijeira SánchezFunder: Asociación Española contra el CáncerAward year 2022 -
Computational BiologyActive
MARGA. Advanced Genomic Architecture Model
Cima Principal Investigator: MikelFunder: Gobierno de NavarraAward year 2022 -
Non-Coding RNA and Regulation of the Cancer GenomeActive
Non-coding RNA and the regulation of cell division and genome stability
Cima Principal Investigator: Maite HuarteFunder: Ministerio de Ciencia e InnovaciónAward year 2022 -
Solid TumorActive
POLIFARMA‐3D Hacia la personalización del tratamiento de infecciones respiratorias crónicas polimicrobianas: evaluación de fármacos sostenibles mediante modelos
Cima Principal Investigator: Carlos Ortiz de Solórzano Aurusa [SP]Funder: Gobierno de NavarraAward year 2022 -
Combination Strategies for Translational ImmunotherapyActive
Integration of 4-1BB (CD 137) agonists, interleukin-12, interleukin-18, and TGF-beta antagonists in synergistic combination strategies for cancer immunotherapy.
Cima Principal Investigator: Ignacio Melero BermejoFunder: Ministerio de Ciencia e InnovaciónAward year 2022 -
Solid TumorActive
AMADIS Oncolung. Development of a test for the non-invasive early diagnosis of lung cancer based on molecular markers, images and Big DataoncoLung Dx tools.
Cima Principal Investigator: Rubén Pío Osés [SP]Funder: Ministerio de Ciencia e InnovaciónAward year 2022 -
Active
SOCRATHeS: Development of innovative CAR-T Therapies for the Treatment of Hematological and Solid Tumors
Funder: Gobierno de NavarraAward year 2022 -
Regenerative MedicineActive
BIOHEART: Advanced bioengineering for developing cardiac tissue and its application to the study and detection of cardiotoxicity.
Cima Principal Investigator: Xabier Aranguren López [SP]Funder: Gobierno de NavarraAward year 2022 -
Immunology and ImmunotherapyActive
ONCOLIBERYX. Nanovectors for direct, loco-regional, and controlled intravenous administration of anti-tumor drugs. Strategies to minimize adverse effects and maximize therapeutic response
Cima Principal Investigator: Ignacio Melero BermejoFunder: Ministerio de Ciencia e InnovaciónAward year 2022 -
Immunology and ImmunotherapyActive
TERINMUN. Exploring marine biodiversity in the search for innovative IMUno-oncological therapies.
Cima Principal Investigator: Ignacio Melero BermejoFunders: Agencia Estatal de Investigación, Ministerio de Ciencia e InnovaciónAward year 2022